Senior Business Development Manager -Cell and Gene Therapy at Thermo Fisher Scientific
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Senior Global Market Development Manager, Cell and Gene Therapy at Thermo Fisher Scientific
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Senior Business Development Manager -Cell and Gene Therapy at Thermo Fisher Scientific
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
Sr. Global Marketing Leader, Cell & Gene Therapy, Protein Expression at Thermo Fisher Scientific
Tune in to hear Fabio Fachin, Ph.D. from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss the current challenges autologous CAR T manufacturers face and how a shortened manufacturing process can address these pain points. Register here: https://lnkd.in/eCWEAJ_x #celltherapymanufacturing
